170 related articles for article (PubMed ID: 31639128)
1. Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts.
Iafolla MAJ; Picardo S; Aung K; Hansen AR
PLoS One; 2019; 14(10):e0222359. PubMed ID: 31639128
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts.
Iafolla MAJ; Picardo S; Aung K; Hansen AR
JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa050. PubMed ID: 33134830
[TBL] [Abstract][Full Text] [Related]
3. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
[TBL] [Abstract][Full Text] [Related]
4. Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.
Joosten SC; Deckers IA; Aarts MJ; Hoeben A; van Roermund JG; Smits KM; Melotte V; van Engeland M; Tjan-Heijnen VC
Epigenomics; 2017 Sep; 9(9):1243-1257. PubMed ID: 28803494
[TBL] [Abstract][Full Text] [Related]
5. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
6. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
[TBL] [Abstract][Full Text] [Related]
9. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
Väänänen T; Kallio J; Vuolteenaho K; Ojala A; Luukkaala T; Hämäläinen M; Tammela T; Kellokumpu-Lehtinen PL; Moilanen E
Scand J Urol; 2017 Oct; 51(5):367-372. PubMed ID: 28644702
[TBL] [Abstract][Full Text] [Related]
10. Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.
Jankova L; Dent OF; Molloy MP; Chan C; Chapuis PH; Howell VM; Clarke SJ
Proteomics Clin Appl; 2015 Dec; 9(11-12):1078-86. PubMed ID: 25755195
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
Lin YL; Wang YP; Li HZ; Zhang X
Med Sci Monit; 2017 Jul; 23():3318-3323. PubMed ID: 28688232
[TBL] [Abstract][Full Text] [Related]
12. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
13. Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
Sekula P; Mallett S; Altman DG; Sauerbrei W
PLoS One; 2017; 12(6):e0178531. PubMed ID: 28614415
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
Li P; Liu J; Li J; Liu P
Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
[TBL] [Abstract][Full Text] [Related]
15. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
16. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
Mallett S; Timmer A; Sauerbrei W; Altman DG
Br J Cancer; 2010 Jan; 102(1):173-80. PubMed ID: 19997101
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
Ellinger J; Gevensleben H; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
[TBL] [Abstract][Full Text] [Related]
18. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.
Sauerbrei W; Taube SE; McShane LM; Cavenagh MM; Altman DG
J Natl Cancer Inst; 2018 Aug; 110(8):803-811. PubMed ID: 29873743
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]